EGFR and colorectal cancer: Tri-specific TCEs targeting CD3, epidermal growth factor receptor (EGFR), and epithelial cellular adhesion molecule (EpCAM) were developed to specifically kill EGFR and/or EpCAM-expressing colorectal cancer cells13.